What is he best known for?
The fields of study he is best known for:
- Gene
- Enzyme
- Internal medicine
Jean D. Sipe focuses on Amyloidosis, Amyloid, Internal medicine, Endocrinology and Serum amyloid A.
His Amyloidosis study deals with Amyloid fibril intersecting with Biochemistry.
His Amyloid study integrates concerns from other disciplines, such as Fibril and Computational biology.
His is doing research in Acute-phase protein, Lipopolysaccharide, Inflammation and Blood proteins, both of which are found in Internal medicine.
The various areas that Jean D. Sipe examines in his Endocrinology study include Spleen, Peritonitis and Enzyme.
His study in Serum amyloid A is interdisciplinary in nature, drawing from both Complement factor B, Molecular biology, Chromatography, Interleukin and Regulation of gene expression.
His most cited work include:
- Review: History of the Amyloid Fibril (787 citations)
- Pretranslational modulation of acute phase hepatic protein synthesis by murine recombinant interleukin 1 (IL-1) and purified human IL-1. (352 citations)
- PTX3, A Prototypical Long Pentraxin, Is an Early Indicator of Acute Myocardial Infarction in Humans (345 citations)
What are the main themes of his work throughout his whole career to date?
His main research concerns Serum amyloid A, Endocrinology, Internal medicine, Acute-phase protein and Amyloid.
His Serum amyloid A research is multidisciplinary, incorporating elements of Lipopolysaccharide, Interleukin, Gene expression and Molecular biology.
The concepts of his Endocrinology study are interwoven with issues in Inflammation, Interleukin 6, Cytokine and Serum Amyloid A Protein.
As part of his studies on Internal medicine, Jean D. Sipe often connects relevant areas like In vivo.
His work deals with themes such as Cell, C-reactive protein, Apolipoprotein B, Lipoprotein and Receptor antagonist, which intersect with Acute-phase protein.
His studies examine the connections between Amyloid and genetics, as well as such issues in Amyloidosis, with regards to Amyloid fibril, Fibril and Systemic amyloidosis.
He most often published in these fields:
- Serum amyloid A (51.32%)
- Endocrinology (42.76%)
- Internal medicine (42.76%)
What were the highlights of his more recent work (between 2001-2020)?
- Amyloidosis (25.00%)
- Amyloid (26.32%)
- Pathology (15.13%)
In recent papers he was focusing on the following fields of study:
His primary areas of study are Amyloidosis, Amyloid, Pathology, Amyloid fibril and Nomenclature Committee.
Jean D. Sipe interconnects Fibril, Computational biology and Immunology in the investigation of issues within Amyloidosis.
His Amyloid research is multidisciplinary, incorporating perspectives in Cell, Pathogenesis, Acute-phase protein, Cell biology and Lipoprotein.
His Pathology study incorporates themes from Serum amyloid A and Physiology.
His study in the field of Serum Amyloid A Protein also crosses realms of Carcinoembryonic antigen.
His Amyloid fibril research is multidisciplinary, relying on both Biochemistry and AA amyloidosis.
Between 2001 and 2020, his most popular works were:
- Nomenclature 2014: Amyloid fibril proteins and clinical classification of the amyloidosis (341 citations)
- Amyloid fibril proteins and amyloidosis: chemical identification and clinical classification International Society of Amyloidosis 2016 Nomenclature Guidelines. (298 citations)
- Amyloid fibril protein nomenclature: 2010 recommendations from the nomenclature committee of the International Society of Amyloidosis (277 citations)
In his most recent research, the most cited papers focused on:
- Gene
- Enzyme
- Internal medicine
His main research concerns Amyloidosis, Pathology, Nomenclature Committee, Amyloid fibril and Amyloid.
The study incorporates disciplines such as Fibril, Computational biology and Protein aggregation in addition to Amyloidosis.
His studies deal with areas such as Amyloid disease and Inclusion bodies as well as Fibril.
Computational biology is closely attributed to Immunology in his work.
A majority of his Cell and molecular biology research is a blend of other scientific areas, such as Systemic amyloidosis and Heparan Sulfate Proteoglycans.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
